Holding announced the launch of Discover23, a new research offering enabling authorized collaborators to securely access the power

But there are facts, law and precedent on point, which are worth examining. First, we can start with 23andMe’s privacy statement, which is—to their credit—strong. In general, data can be ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

Amy Nordrum, executive editor, and Charlotte Jee, news editor. Each year, MIT Technology Review publishes an annual list of the top ten breakthrough technologies that will have the greatest impact on how we live and work in the future.

A complete list of all the known layoffs in tech, from Big Tech to startups, broken down by month throughout 2024. © 2024 TechCrunch. All rights reserved. For personal use only.

The ongoing hacking spree has compromised at least 25 Chrome extensions, potentially affecting over two million users. Cyberhaven, a data protection company, fell victim to the attack.

The IPO market has been largely dormant since late 2021 as rising inflation and rising interest rates pushed investors out of risk. According to a report from Rock Health, few tech companies have gone public since then, and no digital health companies held an IPO in 2023.

Mario Draghi ’s assessment of EU competitiveness last year highlighted Europe’s failure to capitalise on the internet revolution. Over the past two decades, Silicon Valley’s runaway tech sector has accounted for most of the difference between US and European productivity growth.

SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company, today

Vertical farms, woke AI, and 23andMe made our annual list of failed tech ... Hundreds of LLM-powered AI agents spontaneously made friends, invented jobs, and spread religion. Google just launched a ton of new products—including Gemini 2.0, which could ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Now, an alliance between Novartis and genetic testing specialist 23andMe is trying to encourage greater awareness of Lp(a) and improve testing rates. The pilot programme will see a confidential ...